ORTOPEDIJOS CENTRAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,072,141 | 1,232,429 | 1,101,040 | 1,316,956 | 1,550,677 | 1,931,883 | 2,431,095 | 2,736,598 |
| Profit before tax | 1,084 | 1,309 | 101,999 | -14,443 | 24,388 | 6,084 | 26,213 | 109,512 |
| Net profit | 1,084 | 1,309 | 99,813 | -14,443 | 22,600 | 5,596 | 24,767 | 103,650 |
| Equity | 924,528 | 922,320 | 1,022,133 | 979,690 | 1,001,519 | 1,007,115 | 1,031,883 | 1,135,533 |
| Liabilities | 128,426 | 189,162 | 203,800 | 217,794 | 34,003 | 45,573 | 53,652 | 145,674 |
| Non-current assets | 114,611 | 89,096 | 67,307 | 82,338 | 86,078 | 98,374 | 200,940 | 220,907 |
| Current assets | 938,343 | 1,022,386 | 1,158,626 | 1,115,146 | 949,444 | 954,314 | 884,595 | 1,060,300 |
| Total assets | 1,052,954 | 1,111,482 | 1,225,933 | 1,197,484 | 1,035,522 | 1,052,688 | 1,085,535 | 1,281,207 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 343,940 | 414,732 | 477,803 |
| Social insurance contributions | - | - | - | - | - | 186,027 | 233,648 | 274,701 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +11.2% | +15.0% | -10.7% | +19.6% | +17.7% | +24.6% | +25.8% | +12.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.1% | 0.1% | 8.1% | -1.2% | 2.2% | 0.5% | 2.3% | 8.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.1% | 0.1% | 9.8% | -1.5% | 2.3% | 0.6% | 2.4% | 9.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.1% | 0.1% | 9.1% | -1.1% | 1.5% | 0.3% | 1.0% | 3.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.1% | 0.1% | 9.3% | -1.1% | 1.6% | 0.3% | 1.1% | 4.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 21,551 | 26,647 | 23,510 | 27,437 | 29,350 | 32,243 | 36,558 | 37,703 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ORTOPEDIJOS CENTRAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-19 | 2025-02-20 | 430.33 |
| 2025-02-18 | 2025-02-18 | 536.56 |
| 2024-07-24 | 2024-07-31 | 0.04 |
| 2024-06-18 | 2024-06-18 | 72.56 |
| 2024-04-23 | 2024-05-01 | 16.72 |
| 2024-02-19 | 2024-02-21 | 137.31 |
| 2023-11-16 | 2023-11-20 | 0.31 |
| 2023-10-25 | 2023-11-12 | 0.31 |
| 2023-09-18 | 2023-09-20 | 177.86 |
ORTOPEDIJOS CENTRAS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-20 | 2025-03-20 | 1.0 |
| 2025-01-30 | 2025-02-09 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ORTOPEDIJOS CENTRAS, UAB (code 223916310) is a Private Limited Liability Company engaged in retail sale of other medical and orthopaedic goods. In the latest financial year, 2025, revenue increased to €2.74M from €2.43M in 2024 and €1.93M in 2023, indicating a steady two-year upward trend. Net profit also improved significantly, reaching €103.7K in 2025 compared with €24.8K in 2024 and €5.6K in 2023. Profit margin strengthened to 3.8% in 2025 from 1.0% in 2024 and 0.3% in 2023. At year-end 2025, total assets stood at €1.28M, with equity of €1.14M and liabilities of €145.7K. Long-term assets were €220.9K and short-term assets €1.06M. The company’s ratios point to solid financial structure and efficient use of assets, with ROE at 9.1%, ROA at 8.1%, debt-to-equity at 0.13, and asset turnover at 2.14x. Revenue per employee was €38.0K, and profit per employee was €1.4K.